Women at high risk for breast cancer more likely to get MRI when informed directly

March 08, 2017

A study published in the journal Health Communications shows that women at high risk for breast cancer who received a letter informing them of their options for additional imaging with contrast-enhanced MRI of the breast (in addition to a letter sent to their primary care physician) were more likely to return to the center for additional screening with MRI. The letter, which is included in the published paper, may help breast imaging centers navigate the complex legal, ethical and institutional landscapes in a way that increases the likelihood that women will follow through with American Cancer Society breast cancer screening recommendations for adjunct breast screening in women at elevated risk.

The project is a collaboration between Invision Sally Jobe Breast Centers, which contributed the de-identified data, and researchers from the University of Colorado Cancer Center, University of Colorado School of Medicine Department of Radiology and the Colorado School of Public Health.

"Invision Sally Jobe Breast Centers screen about 65,000 women every year for breast cancer and some of these women are at high risk. When Invision Sally Jobe Breast Centers adopted the American Cancer Society recommendations for breast cancer screening, they first only informed referring physicians. Invision Sally Jobe Breast Centers later went on to adopt the practice of informing women of these recommendations directly, in addition to the physicians. So we have a natural experiment where we can compare the two methods of communication," explains Deborah Glueck, PhD, the paper's senior author. Dr. Glueck is a CU Cancer Center investigator and associate professor of radiology and biostatistics at the Colorado School of Public Health.

The paper compares rates of follow-up MRI for women found to have greater than 20 percent risk according to the widely used Gail model risk assessment. The study was split into two periods - one in which the recommendation for additional screening was communicated via letter only to a woman's primary care physician, and one in which recommendations were communicated via letters to both the woman and to her primary care physician. When women were sent a letter informing them of the American Cancer Society additional breast screening recommendations for women at elevated lifetime risk, follow-up screening with breast MRI increased significantly.

"In an earlier study, we noticed that only a small percentage of women were coming back for MRI. This paper is the result of us wondering why," says John Brinton, PhD, assistant research professor at the Colorado School for Public Health, the paper's first author.

However, the researchers point out that their results do not necessarily prove that direct communication caused the increase in follow-up screening. Because this was an observational study, the increase in follow-up screening could have been due to unrelated factors - what the researchers call "secular trends" - such as current events or changes in culture that could have influenced attitudes about MRI screening in these high risk patients.

"We show that this kind of communication is associated with an increased rate of women returning for breast cancer screening with MRI," Glueck says. "But the thing I really care about is whether risk assessment, good communication and breast cancer screening actually save lives, or just cause harms from additional screening."

This is the central question of Glueck and Brinton's continuing line of research. Just now, with data collection pre- and post-adoption of ACS guidelines by many thousands of patients at the Invision Sally Jobe Breast Centers, and with the hope for continued research funding, the team may be able to gather the resources needed to answer Glueck's larger question.
-end-


University of Colorado Anschutz Medical Campus

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.